Cardiology Today
@cardiologytoday
The content you need, when you need it.
ID: 27648004
http://healio.com/cardiology 30-03-2009 14:39:59
33,33K Tweet
51,51K Takipçi
1,1K Takip Edilen
The first trial to evaluate use of an #SGLT2inhibitor in people undergoing TAVR showed benefit with dapagliflozin vs. standard care alone, including in older patients Sergio Raposeiras-Roubín @DapaTAVI #ACC25 @ACCMediaCenter American College of Cardiology healio.com/news/cardiolog…